vs

Side-by-side financial comparison of DLH Holdings Corp. (DLHC) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($76.4M vs $68.9M, roughly 1.1× DLH Holdings Corp.). DLH Holdings Corp. runs the higher net margin — -1.9% vs -39.1%, a 37.2% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (11.9% vs -24.1%). DLH Holdings Corp. produced more free cash flow last quarter ($-4.8M vs $-12.2M). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (31.0% CAGR vs -17.4%).

DLH Holdings Corp. is a U.S.-based provider of technology-enabled healthcare, logistics, engineering, and mission support services primarily serving federal government agencies including the Department of Veterans Affairs, Department of Defense, and Department of Health and Human Services, as well as select state and local government clients across core public service segments.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

DLHC vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.1× larger
PRCT
$76.4M
$68.9M
DLHC
Growing faster (revenue YoY)
PRCT
PRCT
+36.1% gap
PRCT
11.9%
-24.1%
DLHC
Higher net margin
DLHC
DLHC
37.2% more per $
DLHC
-1.9%
-39.1%
PRCT
More free cash flow
DLHC
DLHC
$7.4M more FCF
DLHC
$-4.8M
$-12.2M
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
31.0%
-17.4%
DLHC

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DLHC
DLHC
PRCT
PRCT
Revenue
$68.9M
$76.4M
Net Profit
$-1.3M
$-29.8M
Gross Margin
60.6%
Operating Margin
2.1%
-40.6%
Net Margin
-1.9%
-39.1%
Revenue YoY
-24.1%
11.9%
Net Profit YoY
-218.7%
-58.3%
EPS (diluted)
$-0.09
$-0.54

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DLHC
DLHC
PRCT
PRCT
Q4 25
$68.9M
$76.4M
Q3 25
$81.2M
$83.3M
Q2 25
$83.3M
$79.2M
Q1 25
$89.2M
$69.2M
Q4 24
$90.8M
$68.2M
Q3 24
$96.4M
$58.4M
Q2 24
$100.7M
$53.4M
Q1 24
$101.0M
$44.5M
Net Profit
DLHC
DLHC
PRCT
PRCT
Q4 25
$-1.3M
$-29.8M
Q3 25
$-920.0K
$-21.4M
Q2 25
$289.0K
$-19.6M
Q1 25
$878.0K
$-24.7M
Q4 24
$1.1M
$-18.9M
Q3 24
$2.3M
$-21.0M
Q2 24
$1.1M
$-25.6M
Q1 24
$1.8M
$-26.0M
Gross Margin
DLHC
DLHC
PRCT
PRCT
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Q1 24
56.2%
Operating Margin
DLHC
DLHC
PRCT
PRCT
Q4 25
2.1%
-40.6%
Q3 25
2.8%
-27.8%
Q2 25
4.5%
-28.0%
Q1 25
5.7%
-39.7%
Q4 24
6.2%
-28.9%
Q3 24
6.6%
-38.4%
Q2 24
5.7%
-50.3%
Q1 24
5.9%
-62.1%
Net Margin
DLHC
DLHC
PRCT
PRCT
Q4 25
-1.9%
-39.1%
Q3 25
-1.1%
-25.7%
Q2 25
0.3%
-24.7%
Q1 25
1.0%
-35.8%
Q4 24
1.2%
-27.6%
Q3 24
2.4%
-35.9%
Q2 24
1.1%
-48.0%
Q1 24
1.8%
-58.3%
EPS (diluted)
DLHC
DLHC
PRCT
PRCT
Q4 25
$-0.09
$-0.54
Q3 25
$-0.07
$-0.38
Q2 25
$0.02
$-0.35
Q1 25
$0.06
$-0.45
Q4 24
$0.08
$-0.34
Q3 24
$0.16
$-0.40
Q2 24
$0.08
$-0.50
Q1 24
$0.12
$-0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DLHC
DLHC
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$257.0K
$286.5M
Total DebtLower is stronger
$133.5M
$51.6M
Stockholders' EquityBook value
$112.2M
$365.9M
Total Assets
$283.5M
$508.1M
Debt / EquityLower = less leverage
1.19×
0.14×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DLHC
DLHC
PRCT
PRCT
Q4 25
$257.0K
$286.5M
Q3 25
$125.0K
$294.3M
Q2 25
$194.0K
$302.7M
Q1 25
$196.0K
$316.2M
Q4 24
$451.0K
$333.7M
Q3 24
$342.0K
$196.8M
Q2 24
$423.0K
$214.1M
Q1 24
$238.0K
$225.6M
Total Debt
DLHC
DLHC
PRCT
PRCT
Q4 25
$133.5M
$51.6M
Q3 25
$128.0M
$51.6M
Q2 25
$138.3M
$51.5M
Q1 25
$147.3M
$51.5M
Q4 24
$162.2M
$51.5M
Q3 24
$149.4M
$51.4M
Q2 24
$160.9M
$51.4M
Q1 24
$164.8M
$51.4M
Stockholders' Equity
DLHC
DLHC
PRCT
PRCT
Q4 25
$112.2M
$365.9M
Q3 25
$113.0M
$380.3M
Q2 25
$113.7M
$385.8M
Q1 25
$112.8M
$389.2M
Q4 24
$111.4M
$402.2M
Q3 24
$110.1M
$241.2M
Q2 24
$108.6M
$251.8M
Q1 24
$106.8M
$264.0M
Total Assets
DLHC
DLHC
PRCT
PRCT
Q4 25
$283.5M
$508.1M
Q3 25
$290.7M
$511.5M
Q2 25
$299.3M
$513.1M
Q1 25
$306.6M
$519.4M
Q4 24
$325.0M
$534.0M
Q3 24
$314.4M
$374.1M
Q2 24
$325.0M
$374.4M
Q1 24
$325.9M
$382.9M
Debt / Equity
DLHC
DLHC
PRCT
PRCT
Q4 25
1.19×
0.14×
Q3 25
1.13×
0.14×
Q2 25
1.22×
0.13×
Q1 25
1.31×
0.13×
Q4 24
1.46×
0.13×
Q3 24
1.36×
0.21×
Q2 24
1.48×
0.20×
Q1 24
1.54×
0.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DLHC
DLHC
PRCT
PRCT
Operating Cash FlowLast quarter
$-4.8M
$-10.3M
Free Cash FlowOCF − Capex
$-4.8M
$-12.2M
FCF MarginFCF / Revenue
-7.0%
-15.9%
Capex IntensityCapex / Revenue
0.1%
2.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$29.2M
$-58.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DLHC
DLHC
PRCT
PRCT
Q4 25
$-4.8M
$-10.3M
Q3 25
$10.7M
$-6.6M
Q2 25
$9.6M
$-15.0M
Q1 25
$14.5M
$-17.0M
Q4 24
$-11.5M
$-32.4M
Q3 24
$12.4M
$-18.8M
Q2 24
$4.6M
$-15.7M
Q1 24
$5.2M
$-32.3M
Free Cash Flow
DLHC
DLHC
PRCT
PRCT
Q4 25
$-4.8M
$-12.2M
Q3 25
$10.7M
$-9.5M
Q2 25
$9.4M
$-17.8M
Q1 25
$14.0M
$-18.8M
Q4 24
$-12.1M
$-33.6M
Q3 24
$12.2M
$-19.0M
Q2 24
$4.5M
$-16.8M
Q1 24
$4.9M
$-34.2M
FCF Margin
DLHC
DLHC
PRCT
PRCT
Q4 25
-7.0%
-15.9%
Q3 25
13.1%
-11.4%
Q2 25
11.2%
-22.5%
Q1 25
15.6%
-27.2%
Q4 24
-13.3%
-49.2%
Q3 24
12.7%
-32.6%
Q2 24
4.4%
-31.4%
Q1 24
4.9%
-76.9%
Capex Intensity
DLHC
DLHC
PRCT
PRCT
Q4 25
0.1%
2.4%
Q3 25
0.0%
3.4%
Q2 25
0.3%
3.5%
Q1 25
0.6%
2.7%
Q4 24
0.6%
1.7%
Q3 24
0.2%
0.4%
Q2 24
0.2%
2.0%
Q1 24
0.3%
4.4%
Cash Conversion
DLHC
DLHC
PRCT
PRCT
Q4 25
Q3 25
Q2 25
33.12×
Q1 25
16.52×
Q4 24
-10.35×
Q3 24
5.42×
Q2 24
4.06×
Q1 24
2.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DLHC
DLHC

Sales Channel Directly To Consumer$64.5M94%
Sales Channel Through Intermediary$4.4M6%

PRCT
PRCT

Hand Pieces And Other Consumables$34.1M45%
System Sales And Rentals$27.5M36%
Other$9.8M13%
Service Revenue$5.0M7%

Related Comparisons